Rare diseases
Investigational molecules
Locations
58 Rue Montalembert, 63003 Clermont Ferrand, France
Clinical research includes head and neck cancer and esophageal squamous cell carcinoma, with attention to perioperative support, symptom management, and treatment strategies in advanced disease.
Research activity also extends to surgical oncology contexts where functional recovery and supportive care are relevant to treatment planning.
University Hospital Of Clermont-Ferrand runs clinical trials in conditions such as Osteoarthritis, Osteoporotic fracture, Post lumbar puncture syndrome, Oesophageal squamous cell carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Preventing Neuropathic Pain After Osteoporotic Vertebral Fracture with a 5% Lidocaine Patch in Adults
FranceComparing Sphenopalatine Block Using Lidocaine and Prilocaine to Blood Patch for Patients with Post-Dural Puncture Syndrome
FranceStudy on Tislelizumab for Elderly Patients with Advanced Esophageal Squamous Cell Carcinoma Unfit for Chemotherapy
FranceStudy on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension
FranceStudy on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy
FranceStudy on Managing Moderate to Severe Limb Trauma Pain in Emergency Patients Using Sublingual Sufentanil Compared to a Drug Combination
FranceStudy on the Effects of Testosterone Gel on Physical Performance in Critically Ill Patients Requiring Long-Term Mechanical Ventilation
FranceStudy on Blood Flow in the Vaginal Area After Total Laparoscopic Hysterectomy Using Indocyanine Green for Patients Undergoing Hysterectomy
FranceStudy on Capsaicin for Finger Pain in Digital Osteoarthritis Patients
FranceStudy on Walking Rehabilitation for Hip or Knee Osteoarthritis Using Ketoprofen and Drug Combination for Patients with Osteoarthritis
FranceEvaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients
FranceA study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
